Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Michelle Krause

TitleChief of Clinical Officer
InstitutionUniversity of Arkansas for Medical Sciences
DepartmentCORE IOP NC, College of Integrated Clinical Enterprise
Address6B 146 VA Little Rock
4301 W.Markham
Mail Slot # 610
Little Rock AR 72205
Phone501-686-7090
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R21DK097470     (DELGADO, PEDRO L)Aug 19, 2013 - Jul 31, 2016
    NIH
    Bupropion for Depression in ESRD Patients on Hemodialysis
    Role: Co-Investigator
    AKI     (KRAUSE, MICHELLE W)Nov 26, 2012
    Thrasos Innovation, Inc
    Observational Data Collection of Acute Kidney Injury Rates Post-Cardiothoracic Surgery
    Role: Principal Investigator
    FG     (KRAUSE, MICHELLE)May 12, 2009 - May 11, 2011
    FibroGen, Inc.
    A randomized, single-blind, placebo-controlled, 4-week treatment study of the safety and biologic activity of escalating multiple oral doses of FG-459
    Role: Principal Investigator
    FG-4592     (KRAUSE, MICHELLE W)May 12, 2009 - May 11, 2011
    FibroGen, Inc.
    A randomized, single-blind, placebo-controlled, 4-week treatment study of the safety and biologic activity of escalating multiple oral doses of FG-459
    Role: Principal Investigator
    CLAF237A23138     (KRAUSE, MICHELLE W)Dec 3, 2008 - Jan 31, 2011
    NOVARTIS Pharmaceuticals Corporation
    CLAF237A231385-A multi-center, randomized, double-blind, active-controlled clinical trial to evaluate the safety and tolerability of 24 weeks treatmen
    Role: Principal Investigator
    CRA Protocol N3700g     (KRAUSE, MICHELLE W)Jul 29, 2008 - Dec 31, 2008
    Genentech, Inc.
    A Phase III, Randomized, Double-Blind, Placebo-controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters; P
    Role: Principal Investigator
    CRAProtocolN3700g     (KRAUSE, MICHELLE W)Jul 29, 2008 - Dec 31, 2008
    Genentech, Inc.
    A Phase III, Randomized, Double-Blind, Placebo-controlled Study of Tenecteplase for Restoration of Function in Dysfunctional Hemodialysis Catheters; P
    Role: Principal Investigator
    FGCL-SM2216     (KRAUSE, MICHELLE)Nov 13, 2006 - Dec 11, 2008
    FibroGen, Inc.
    FGCL-SM2216-019: A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects with Renal Anemia Not Requiring Dialysis and Not Receiving Recom
    Role: Principal Investigator
    FGCL-SM2216-019 CTA     (KRAUSE, MICHELLE W)Nov 13, 2006 - Dec 11, 2008
    FibroGen, Inc.
    FGCL-SM2216-019: A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects with Renal Anemia Not Requiring Dialysis and Not Receiving Recom
    Role: Principal Investigator
    U01DK63455     (KRAUSE, MICHELLE W)Apr 10, 2006 - Aug 31, 2008
    NIH/Nat. Inst. of Diabetes & Digestive & Kidney Diseases - Pass Through: University of North Carolina - Chapel Hill
    FSGS-CT: Multicenter Trial of Focal Glomerulosclerosis
    Role: Principal Investigator
    ARIA 14937 20010184 CTA     (KRAUSE, MICHELLE W)Nov 1, 2004 - Nov 3, 2008
    Amgen, Inc.
    Protocol 20010184: Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
    Role: Principal Investigator
    ARIA1493720010184CTA     (KRAUSE, MICHELLE W)Nov 1, 2004 - Nov 3, 2008
    Amgen, Inc.
    Protocol 20010184: Trial to Reduce Cardiovascular Events with Aranesp Therapy (TREAT)
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions. Don't see publications published under other names? Login to add alternative names.
    List All   |   Timeline
    1. Patil S, Subramany S, Patil S, Gurram P, Singh M, Krause M. Ibuprofen Abuse-A Case of?Rhabdomyolysis, Hypokalemia, and?Hypophosphatemia With Drug-Induced Mixed Renal Tubular Acidosis. Kidney Int Rep. 2018 Sep; 3(5):1237-1238. PMID: 30197993.
      View in: PubMed
    2. Sethi S, Pothineni NK, Syal G, Ali SM, Krause MW. Aortic intimal sarcoma masquerading as bilateral renal artery stenosis. J Nephrol. 2013 Sep-Oct; 26(5):941-4. PMID: 24052470.
      View in: PubMed
    3. Krause M, Alam M. UptoDate. Peritoneal Dialysis Solutions. 2012.
    4. Krause MW, Fonseca VA, Shah SV. Combination inhibition of the renin-angiotensin system: is more better? Kidney Int. 2011 Aug; 80(3):245-55. PMID: 21633407.
      View in: PubMed
    5. Krause M, Fonseca V, Shah SV. Combination Inhibition of the Renin Angiotensin. Kid Int. 2011; (80):245-255.
    6. Sethi S, Ali SM, Govindarajan R, Krause M. Aortic Intimal Sarcoma Masquerading as Bilateral Renal Artery Stenosis. American College of Physicians Annual Meeting; 2011. American College of Physicians Annual Meeting. 2011.
    7. Sethi S, Kaur V, Rotaru D, Gokden N, Krause M. IgA Postinfectious Glomerulonephritis in an Elderly Male: A Rare Case. American College of Physicians ; 2011. American College of Physicians. 2011.
    8. Krause M. Medical Knowledge Self Assessment Program (MKSAP). Nephrolithiasis. 2009.
    9. Krause M. Medical Knowledge Self Assessment Program (MKSAP). Evaluation of Kidney Function. 2009.
    10. Krause M. Medical Knowledge Self Assessment Program (MKSAP). Tubulointerstitial Disorders. 2009.
    11. Krause MW, Raja R, Agarwal A, Silver MR, Scarlata D, Sciarra A, Kewalramani R. Every-other-week darbepoetin alfa in the correction and maintenance of haemoglobin levels in elderly patients with chronic kidney disease: post hoc subanalysis of data from two clinical trials. Drugs Aging. 2009; 26(8):665-75. PMID: 19685932.
      View in: PubMed
    12. Silver MR, Agarwal A, Krause M, Lei L, Stehman-Breen C. Effect of darbepoetin alfa administered once monthly on maintaining hemoglobin levels in older patients with chronic kidney disease. Am J Geriatr Pharmacother. 2008 Jun; 6(2):49-60. PMID: 18675764.
      View in: PubMed
    13. Krause M, Shah SV. Chronic Kidney Disease. BMJ Publishing Group Ltd. 2008.
    14. Barone GW, Wright CF, Krause MW, Brosnahan GM, Portilla D, Banerjee S, McCowan TC, Culp WC, Yousaf M. Hemodialysis access success: beyond the operating room. Am J Surg. 2007 Nov; 194(5):668-71. PMID: 17936432.
      View in: PubMed
    15. Krause M. Medical Knowledge Self Assessment Program (MKSAP). Evaluation of Kidney Function. 2007.
    16. Krause M. Medical Knowledge Self Assessment Program (MKSAP). Tubulointerstitial Disorders. 2007.
    17. Krause M, Agarwal A, Silver MR, Klassen P, Kewalramani R. De Novo Every-other-week (Q2W) Darbepoetin alfa Used to Correct Hemoglobin (Hb) Levels in Older Chronic Kidney Disease (CKD) Subjects Naïve to Erythropoiesis-stimulating Protein (ESP) Treatment. American Geriatric Society. 2007.
    18. Krause M, Raja R, Agarwal A, Silver MR, Scarlata D, Sciarra A, Audhya P. De Novo Darbepoetin alfa Treatment Administered Every Other Week (Q2W) Corrects and Maintains Hemoglobin (Hb) Levels in Older Patients With Chronic Kidney Disease (CKD). 2007.
    19. Krause M. Medical Knowledge Self Assessment Program (MKSAP). Nephrolithiasis. 2007.
    20. Krause M, Walker PD. Andreoli and Carpenter's Cecil Essentials of Medicine. Glomerular Diseases. 2006.
    21. Krause M, Shah SV. Andreoli and Carpenter's Cecil Essentials of Medicine. Approach to the Patient with Renal Disease. 2006.
    22. Silver MR, Krause M, Agarwal A, Liu W, Audhya P. Once-monthly (QM) Aransep (Darbepoetin alfa) Maintains Target Hemoglobin (Hb) Levels in Older Patients with Chronic Kidney disease (CKD). 2006.
    23. Agarwal A, Krause M, Silver M, Liu W, Audhya P. Once-monthly Darbepoetin alfa effectively maintains hemoglobin levels in older patients with chronic kidney disease. 2006.
    24. Hansberry MR, Whittier WL, Krause MW. The elderly patient with chronic kidney disease. Adv Chronic Kidney Dis. 2005 Jan; 12(1):71-7. PMID: 15719336.
      View in: PubMed
    25. Krause M, Shah SV. Clinical Obstetrics: The Fetus and Mother. Pregnancy Complicated by Renal Disorders. 2005.
    26. Krause MW, Massing M, Kshirsagar A, Rosamond W, Simpson RJ. Combination therapy improves survival after acute myocardial infarction in the elderly with chronic kidney disease. Ren Fail. 2004 Nov; 26(6):715-25. PMID: 15600265.
      View in: PubMed
    27. Alam MG, Krause MW, Shah SV. Parenteral iron therapy: beyond anaphylaxis. Kidney Int. 2004 Jul; 66(1):457-8. PMID: 15200457.
      View in: PubMed
    28. Bhargava P, Krause M, Abul-Ezz S. GFR Estimation in Renal Transplant Recipients with Allograft Dysfunction. North American Society of Dialysis and Transplantation. 2003.
    29. Krause M, Rosamond W, Massing M, Kshirsagar A, Simpson R. The Effect of Cardioprotective Medications after Acute Myocardial Infarction in an Elderly Cohort with Chronic Kidney Disease. J Am Soc of Neph 13:436A, 2002. 2002.
    30. Whittier M, Finn WF. Netter's Textbook of Internal Medicine. Acute Renal Failure. 2002.
    31. Wang HY, Wang M, Krause M. Molitoris and Finn Acute Renal Failure: A Companion to Brenner and Rector's The Kidney. Biological Nephrotoxins. 2001.
    Krause's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    See all (62) concept(s)
    _
    Co-Authors Expand Description
    See all (2) people
    _
    Similar People Expand Description
    See all (27) people
    _
    Same Department Expand Description
    Search Department